Study of LAU-7b for the Treatment of COVID-19 Disease in Adults
Status:
Completed
Trial end date:
2021-07-15
Target enrollment:
Participant gender:
Summary
A randomized, double-blind, placebo-controlled Phase 2 Study of LAU-7b against confirmed
COVID-19 Disease in hospitalized patients at a higher risk of complications.